Fingerprint
Dive into the research topics of 'Anti-PD-1 therapy in patients with advanced melanoma and preexisting autoimmune disorders or major toxicity with ipilimumab'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Anti-PD-1 therapy in patients with advanced melanoma and preexisting autoimmune disorders or major toxicity with ipilimumab
Alexander M. Menzies*, D. B. Johnson, S. Ramanujam, V. G. Atkinson, A. N.M. Wong, J. J. Park, J. L. McQuade, A. N. Shoushtari, K. K. Tsai, Z. Eroglu, O. Klein, J. C. Hassel, J. A. Sosman, A. Guminski, R. J. Sullivan, A. Ribas, M. S. Carlino, M. A. Davies, S. K. Sandhu, G. V. Long
*Corresponding author for this work
Research output: Contribution to journal › Article › peer-review
606
Scopus
citations